Clinical Trial Details

Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy With or Without Radiotherapy as Adjuvant Treatment for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

IRB Protocol Number
GOG 3122 DESTINY

Clinical Trial Categories

  • Endometrial Cancer
Contact
Clinical Trials at 910-715-2200

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.